CERBA
Aziz Kinani has extensive experience in the field of chemistry, currently serving as Responsable des méthodes at CERBA since November 2019. Prior to this role, Aziz worked as Chef de projet en chimie at the European Research Institute on Natural Ingredients from January 2019 to November 2019 and as Ingénieur de recherche en chimie at Université Paris-Sud between February 2017 and January 2019. Earlier experience includes a position at EDF from February 2014 to January 2017, during which Aziz completed a PhD in analytical chemistry. Aziz holds a Doctor of Philosophy in analytical and environmental chemistry from École Polytechnique (2014-2017) and a Master II in fine polymer chemistry and analysis from CY Cergy Paris Université (2012-2013).
This person is not in any teams
This person is not in any offices
CERBA
FR// Créé en 1967, accrédité selon la norme NF ISO 15189 depuis 1999, CERBA est le leader européen de la biologie médicale spécialisée. Concentrant plus de 40 spécialités médicales et employant plus de 600 personnes hautement qualifiées sur un site unique basé au nord-ouest de Paris, le laboratoire CERBA traite en moyenne 40 000 prélèvements par jour. Sa plateforme technologique de pointe lui permet de proposer aux laboratoires privés et hospitaliers sur plus de 50 pays un large panel d’examens de biologie spécialisée. CERBA développe constamment son potentiel technologique et humain et initie de nombreuses collaborations avec des structures publiques et privées pour être à la pointe de l’innovation. Depuis 1998, les équipes de CERBA ont participé à plus de 500 publications scientifiques. CERBA est par ailleurs le membre fondateur du groupe CERBA HEALTHCARE EN// Created in 1967 and accredited in compliance with the NF ISO 15189 standard since 1999, CERBA is the European leader in specialized clinical pathology. Integrating more than 40 medical specialties and employing over 600 highly qualified staff on a single site located to the north-west of Paris, on average CERBA handles some 40,000 dossiers daily. With a state-of-the-art technological platform, it is able to offer private and hospital laboratories in over 50 countries a wide range of specialized clinical pathology tests. CERBA ceaselessly works to develop its technological and human potential and has launched numerous collaborative projects with both public and private establishments to ensure it always remains on the leading-edge of innovation. Since 1998, CERBA's pathologists have contributed to over 500 scientific publications. CERBA is also a founder member of the CERBA HEALTHCARE group.